The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10 November 2024 in bustling Portuguese city of Lisbon. Being the only European multi-disciplinary gathering for urological cancers, EMUC24 will delve into the very latest developments in the prevention, diagnosis and management of genito-urinary (GU) cancers.
Delegates will also receive the AI-related developments from the EAU Imaging Section during the ESUI Plenary Session 1 “Artificial intelligence: Is it ready for screening? The ProCancer-I experience”, presented by Dr Papanikolaou, focusing on how AI is revolutionizing prostate cancer care. Dr Papanikolaou will also be sharing the groundbreaking experiences and findings from the flagship European-funded project—the European Federation for Cancer Images (EUCAIM).
